-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Aytu Biopharma, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
- Aytu Biopharma, Inc Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was $788K.
- Aytu Biopharma, Inc Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$5.24M, a 70.9% increase year-over-year.
- Aytu Biopharma, Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$15.8M, a 7.08% increase from 2023.
- Aytu Biopharma, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$17.1M, a 84.3% increase from 2022.
- Aytu Biopharma, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$109M, a 86.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)